Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 490

1.

VHH characterization.Recombinant VHHs: Production, characterization and affinity.

Chabrol E, Stojko J, Nicolas A, Botzanowski T, Fould B, Antoine M, Cianférani S, Ferry G, Boutin JA.

Anal Biochem. 2019 Oct 30;589:113491. doi: 10.1016/j.ab.2019.113491. [Epub ahead of print]

PMID:
31676284
2.

Antimalarial Properties of Dunnione Derivatives as NQO2 Substrates.

Chhour M, Aubouy A, Bourgeade-Delmas S, Pério P, Ternet-Fontebasso H, Haidara M, Ferry G, Nepveu F, Boutin JA, Reybier K.

Molecules. 2019 Oct 15;24(20). pii: E3697. doi: 10.3390/molecules24203697.

3.

One Health, Only the Future Counts.

Boutin JP.

Med Sante Trop. 2019 Aug 1;29(3):229. doi: 10.1684/mst.2019.0907. No abstract available.

4.

Cerebrospinal meningitis: lessons learnt from Africa.

Simon F, Boutin JP, Milleliri JM, Tournier JN.

Lancet Infect Dis. 2019 Oct;19(10):1056. doi: 10.1016/S1473-3099(19)30479-7. No abstract available. Erratum in: Lancet Infect Dis. 2019 Oct 9;:.

PMID:
31559957
5.
6.

VHH characterization. Comparison of recombinant with chemically synthesized anti-HER2 VHH.

Hartmann L, Botzanowski T, Galibert M, Jullian M, Chabrol E, Zeder-Lutz G, Kugler V, Stojko J, Strub JM, Ferry G, Frankiewicz L, Puget K, Wagner R, Cianférani S, Boutin JA.

Protein Sci. 2019 Oct;28(10):1865-1879. doi: 10.1002/pro.3712. Epub 2019 Aug 29.

PMID:
31423659
7.

The PINK1 kinase-driven ubiquitin ligase Parkin promotes mitochondrial protein import through the presequence pathway in living cells.

Jacoupy M, Hamon-Keromen E, Ordureau A, Erpapazoglou Z, Coge F, Corvol JC, Nosjean O, Mannoury la Cour C, Millan MJ, Boutin JA, Harper JW, Brice A, Guedin D, Gautier CA, Corti O.

Sci Rep. 2019 Aug 14;9(1):11829. doi: 10.1038/s41598-019-47352-9.

8.

Importance of the Choice of a Recombinant System to Produce Large Amounts of Functional Membrane Protein hERG.

Vasseur L, Cens T, Wagner R, Saint N, Kugler V, Chavanieu A, Ouvry C, Dupré C, Ferry G, Boutin JA.

Int J Mol Sci. 2019 Jun 28;20(13). pii: E3181. doi: 10.3390/ijms20133181.

9.

Renal outcome after simultaneous heart and kidney transplantation.

Toinet T, Dominique I, Cholley I, Vanalderwerelt V, Goujon A, Paret F, Bessede T, Delaporte V, Salomon L, Badet L, Boutin JM, Verhoest G, Branchereau J, Timsit MO; Renal Transplantation Committee of the French Urological Association (CTAFU).

Clin Transplant. 2019 Jul;33(7):e13615. doi: 10.1111/ctr.13615. Epub 2019 Jun 19.

PMID:
31215696
10.
11.

Pierre Richet (1904-1983), fighting onchocerciasis and totalitarism.

Boutin JP, Milleliri JM.

Med Sante Trop. 2019 Feb 1;29(1):15-20. doi: 10.1684/mst.2019.0871.

12.

LC-MS/MS measurements of urinary guanidinoacetic acid and creatine: Method optimization by deleting derivatization step.

Benoit R, Samir M, Boutin J, Samuel A, Brigitte C, Dominique D, Isabelle RV.

Clin Chim Acta. 2019 Jun;493:148-155. doi: 10.1016/j.cca.2019.03.007. Epub 2019 Mar 9.

PMID:
30858092
13.

General lack of structural characterization of chemically synthesized long peptides.

Boutin JA, Tartar AL, van Dorsselaer A, Vaudry H.

Protein Sci. 2019 May;28(5):857-867. doi: 10.1002/pro.3601. Epub 2019 Mar 25. Review.

PMID:
30851143
14.

CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations.

Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, Teichmann M, Rousseau E, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, Lalanne M, Prouzet-Mauléon V, Turcq B, Ged C, Blouin JM, Richard E, Dabernat S, Moreau-Gaudry F, Bedel A.

Nat Commun. 2019 Mar 8;10(1):1136. doi: 10.1038/s41467-019-09006-2.

15.

S29434, a Quinone Reductase 2 Inhibitor: Main Biochemical and Cellular Characterization.

Boutin JA, Bouillaud F, Janda E, Gacsalyi I, Guillaumet G, Hirsch EC, Kane DA, Nepveu F, Reybier K, Dupuis P, Bertrand M, Chhour M, Le Diguarher T, Antoine M, Brebner K, Da Costa H, Ducrot P, Giganti A, Goswami V, Guedouari H, Michel PP, Patel A, Paysant J, Stojko J, Viaud-Massuard MC, Ferry G.

Mol Pharmacol. 2019 Mar;95(3):269-285. doi: 10.1124/mol.118.114231. Epub 2018 Dec 19.

16.

Is There Sufficient Evidence that the Melatonin Binding Site MT3 Is Quinone Reductase 2?

Boutin JA, Ferry G.

J Pharmacol Exp Ther. 2019 Jan;368(1):59-65. doi: 10.1124/jpet.118.253260. Epub 2018 Nov 2. Review.

PMID:
30389722
17.

Design, Synthesis, Molecular Dynamics Simulation, and Functional Evaluation of a Novel Series of 26RFa Peptide Analogues Containing a Mono- or Polyalkyl Guanidino Arginine Derivative.

Alim K, Lefranc B, Sopkova-de Oliveira Santos J, Dubessy C, Picot M, Boutin JA, Vaudry H, Chartrel N, Vaudry D, Chuquet J, Leprince J.

J Med Chem. 2018 Nov 21;61(22):10185-10197. doi: 10.1021/acs.jmedchem.8b01332. Epub 2018 Nov 7.

PMID:
30358997
18.

Gene expression profiling during hibernation in the European hamster.

Gautier C, Bothorel B, Ciocca D, Valour D, Gaudeau A, Dupré C, Lizzo G, Brasseur C, Riest-Fery I, Stephan JP, Nosjean O, Boutin JA, Guénin SP, Simonneaux V.

Sci Rep. 2018 Sep 3;8(1):13167. doi: 10.1038/s41598-018-31506-2.

19.

A highly efficient, one-step purification of the Hsp70 chaperone Ssa1.

Griffith AA, Boutin J, Holmes W.

Protein Expr Purif. 2018 Dec;152:56-63. doi: 10.1016/j.pep.2018.07.006. Epub 2018 Jul 17.

20.

Hamster Melatonin Receptors: Cloning and Binding Characterization of MT₁ and Attempt to Clone MT₂.

Gautier C, Dufour E, Dupré C, Lizzo G, Caignard S, Riest-Fery I, Brasseur C, Legros C, Delagrange P, Nosjean O, Simonneaux V, Boutin JA, Guenin SP.

Int J Mol Sci. 2018 Jul 4;19(7). pii: E1957. doi: 10.3390/ijms19071957.

21.

Natural Inhibitors of the RhoA-p115 Complex from the Bark of Meiogyne baillonii.

Olivon F, Nothias LF, Dumontet V, Retailleau P, Berger S, Ferry G, Cohen W, Pfeiffer B, Boutin JA, Scalbert E, Roussi F, Litaudon M.

J Nat Prod. 2018 Jul 27;81(7):1610-1618. doi: 10.1021/acs.jnatprod.8b00209. Epub 2018 Jul 3.

PMID:
29969260
22.

Intradetrusor Injections of Botulinum Toxin A in Adults with Spinal Dysraphism.

Peyronnet B, Even A, Capon G, De Seze M, Hascoet J, Biardeau X, Baron M, Perrouin-Verbe MA, Boutin JM, Saussine C, Phé V, Lenormand L, Chartier-Kastler E, Cornu JN, Karsenty G, Manunta A, Schurch B, Denys P, Amarenco G, Game X; GENULF and the AFU Committee of NeuroUrology.

J Urol. 2018 Oct;200(4):875-880. doi: 10.1016/j.juro.2018.05.006. Epub 2018 May 8.

PMID:
29746860
23.

A structural study of the complex between neuroepithelial cell transforming gene 1 (Net1) and RhoA reveals a potential anticancer drug hot spot.

Petit AP, Garcia-Petit C, Bueren-Calabuig JA, Vuillard LM, Ferry G, Boutin JA.

J Biol Chem. 2018 Jun 8;293(23):9064-9077. doi: 10.1074/jbc.RA117.001123. Epub 2018 Apr 25.

24.

GHSR-D2R heteromerization modulates dopamine signaling through an effect on G protein conformation.

Damian M, Pons V, Renault P, M'Kadmi C, Delort B, Hartmann L, Kaya AI, Louet M, Gagne D, Ben Haj Salah K, Denoyelle S, Ferry G, Boutin JA, Wagner R, Fehrentz JA, Martinez J, Marie J, Floquet N, Galès C, Mary S, Hamm HE, Banères JL.

Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):4501-4506. doi: 10.1073/pnas.1712725115. Epub 2018 Apr 9.

25.

Characterization of the Mel1c melatoninergic receptor in platypus (Ornithorhynchus anatinus).

Gautier C, Guenin SP, Riest-Fery I, Perry TJ, Legros C, Nosjean O, Simonneaux V, Grützner F, Boutin JA.

PLoS One. 2018 Mar 12;13(3):e0191904. doi: 10.1371/journal.pone.0191904. eCollection 2018.

26.

Oxidative stress and neurodegeneration: The possible contribution of quinone reductase 2.

Cassagnes LE, Chhour M, Pério P, Sudor J, Gayon R, Ferry G, Boutin JA, Nepveu F, Reybier K.

Free Radic Biol Med. 2018 May 20;120:56-61. doi: 10.1016/j.freeradbiomed.2018.03.002. Epub 2018 Mar 8.

PMID:
29526807
27.

Robot-assisted renal transplantation using the retroperitoneal approach (RART) with more than one year follow up: Description of the technique and results.

Bruyère F, Pradère B, Faivre d'Arcier B, Boutin JM, Buchler M, Brichart N.

Prog Urol. 2018 Jan;28(1):48-54. doi: 10.1016/j.purol.2017.10.002. Epub 2017 Nov 20.

PMID:
29158031
28.

Assessments of cellular melatonin receptor signaling pathways: β-arrestin recruitment, receptor internalization, and impedance variations.

Dupré C, Bruno O, Bonnaud A, Giganti A, Nosjean O, Legros C, Boutin JA.

Eur J Pharmacol. 2018 Jan 5;818:534-544. doi: 10.1016/j.ejphar.2017.11.022. Epub 2017 Nov 15.

PMID:
29154938
29.

Management of renal transplant urolithiasis: a multicentre study by the French Urology Association Transplantation Committee.

Branchereau J, Timsit MO, Neuzillet Y, Bessède T, Thuret R, Gigante M, Tillou X, Codas R, Boutin J, Doerfler A, Sallusto F, Culty T, Delaporte V, Brichart N, Barrou B, Salomon L, Karam G, Rigaud J, Badet L, Kleinklauss F.

World J Urol. 2018 Jan;36(1):105-109. doi: 10.1007/s00345-017-2103-8. Epub 2017 Oct 22.

PMID:
29058024
30.

Crystallization via tubing microfluidics permits both in situ and ex situ X-ray diffraction.

Gerard CJJ, Ferry G, Vuillard LM, Boutin JA, Chavas LMG, Huet T, Ferte N, Grossier R, Candoni N, Veesler S.

Acta Crystallogr F Struct Biol Commun. 2017 Oct 1;73(Pt 10):574-578. doi: 10.1107/S2053230X17013826. Epub 2017 Oct 2.

31.

Binding mode prediction and MD/MMPBSA-based free energy ranking for agonists of REV-ERBα/NCoR.

Westermaier Y, Ruiz-Carmona S, Theret I, Perron-Sierra F, Poissonnet G, Dacquet C, Boutin JA, Ducrot P, Barril X.

J Comput Aided Mol Des. 2017 Aug;31(8):755-775. doi: 10.1007/s10822-017-0040-7. Epub 2017 Jul 15.

PMID:
28712038
32.

New MT₂ Melatonin Receptor-Selective Ligands: Agonists and Partial Agonists.

Boutin JA, Bonnaud A, Brasseur C, Bruno O, Lepretre N, Oosting P, Coumailleau S, Delagrange P, Nosjean O, Legros C.

Int J Mol Sci. 2017 Jun 23;18(7). pii: E1347. doi: 10.3390/ijms18071347.

33.

W2476 ameliorates β-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway.

Li T, Lin GY, Zhong L, Zhou Y, Wang J, Zhu Y, Feng Y, Cai XQ, Liu Q, Nosjean O, Boutin JA, Renard P, Yang DH, Wang MW.

Acta Pharmacol Sin. 2017 Jul;38(7):1024-1037. doi: 10.1038/aps.2017.15. Epub 2017 May 15.

34.

Cryo-electron microscopy and X-ray crystallography: complementary approaches to structural biology and drug discovery.

Vénien-Bryan C, Li Z, Vuillard L, Boutin JA.

Acta Crystallogr F Struct Biol Commun. 2017 Apr 1;73(Pt 4):174-183. doi: 10.1107/S2053230X17003740. Epub 2017 Mar 29. Review.

35.

Role of Quinone Reductase 2 in the Antimalarial Properties of Indolone-Type Derivatives.

Cassagnes LE, Rakotoarivelo N, Sirigu S, Pério P, Najahi E, Chavas LM, Thompson A, Gayon R, Ferry G, Boutin JA, Valentin A, Reybier K, Nepveu F.

Molecules. 2017 Jan 30;22(2). pii: E210. doi: 10.3390/molecules22020210.

36.

New quinolinic derivatives as melatonergic ligands: Synthesis and pharmacological evaluation.

Landagaray E, Ettaoussi M, Rami M, Boutin JA, Caignard DH, Delagrange P, Melnyk P, Berthelot P, Yous S.

Eur J Med Chem. 2017 Feb 15;127:621-631. doi: 10.1016/j.ejmech.2016.12.013. Epub 2017 Jan 3.

PMID:
28131094
37.

Screening ubiquitin specific protease activities using chemically synthesized ubiquitin and ubiquitinated peptides.

Bacchi M, Fould B, Jullian M, Kreiter A, Maurras A, Nosjean O, Coursindel T, Puget K, Ferry G, Boutin JA.

Anal Biochem. 2017 Feb 15;519:57-70. doi: 10.1016/j.ab.2016.12.014. Epub 2016 Dec 18.

PMID:
27993553
38.

Total chemical synthesis, refolding, and crystallographic structure of fully active immunophilin calstabin 2 (FKBP12.6).

Bacchi M, Jullian M, Sirigu S, Fould B, Huet T, Bruyand L, Antoine M, Vuillard L, Ronga L, Chavas LM, Nosjean O, Ferry G, Puget K, Boutin JA.

Protein Sci. 2016 Dec;25(12):2225-2242. doi: 10.1002/pro.3051. Epub 2016 Oct 13.

39.

[Cryo-microscopy, an alternative to the X-ray crystallography?].

Boutin JA, Li Z, Vuillard L, Vénien-Bryan C.

Med Sci (Paris). 2016 8-9;32(8-9):758-67. doi: 10.1051/medsci/20163208025. Epub 2016 Sep 12. Review. French.

40.

Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.

Les F, Deleruyelle S, Cassagnes LE, Boutin JA, Balogh B, Arbones-Mainar JM, Biron S, Marceau P, Richard D, Nepveu F, Mauriège P, Carpéné C.

Chem Biol Interact. 2016 Oct 25;258:115-25. doi: 10.1016/j.cbi.2016.07.014. Epub 2016 Jul 28.

PMID:
27475863
41.

Molecular Dynamics Simulations and Kinetic Measurements to Estimate and Predict Protein-Ligand Residence Times.

Mollica L, Theret I, Antoine M, Perron-Sierra F, Charton Y, Fourquez JM, Wierzbicki M, Boutin JA, Ferry G, Decherchi S, Bottegoni G, Ducrot P, Cavalli A.

J Med Chem. 2016 Aug 11;59(15):7167-76. doi: 10.1021/acs.jmedchem.6b00632. Epub 2016 Jul 22.

PMID:
27391254
42.

High-throughput drug profiling with voltage- and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes.

Bedut S, Seminatore-Nole C, Lamamy V, Caignard S, Boutin JA, Nosjean O, Stephan JP, Coge F.

Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H44-53. doi: 10.1152/ajpheart.00793.2015. Epub 2016 May 3.

43.

Melatonergic ligands: Design, synthesis and pharmacological evaluation of novel series of naphthofuranic derivatives.

Landagaray E, Ettaoussi M, Duroux R, Boutin JA, Caignard DH, Delagrange P, Melnyk P, Berthelot P, Yous S.

Eur J Med Chem. 2016 Feb 15;109:360-70. doi: 10.1016/j.ejmech.2015.12.047. Epub 2015 Dec 29.

PMID:
26820449
44.

Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.

Legros C, Brasseur C, Delagrange P, Ducrot P, Nosjean O, Boutin JA.

J Pharmacol Exp Ther. 2016 Mar;356(3):681-92. doi: 10.1124/jpet.115.229989. Epub 2016 Jan 12.

PMID:
26759496
45.

Detergent-free Isolation of Functional G Protein-Coupled Receptors into Nanometric Lipid Particles.

Logez C, Damian M, Legros C, Dupré C, Guéry M, Mary S, Wagner R, M'Kadmi C, Nosjean O, Fould B, Marie J, Fehrentz JA, Martinez J, Ferry G, Boutin JA, Banères JL.

Biochemistry. 2016 Jan 12;55(1):38-48. doi: 10.1021/acs.biochem.5b01040. Epub 2015 Dec 24.

PMID:
26701065
46.

Étude multicentrique sur les traitements conservateurs des tumeurs du greffon : vers les traitements ablatifs ?

Guleryuz K, Doerfler A, Bensadoun H, Boutin J, Bouyé S, Chambade D, Codas R, Coffin G, Devonec M, Erauso A, Hubert J, Karam G, Lechevallier E, Salomon L, Sénéchal C, Sallusto F, Terrier N, Timsit M, Thuret R, Verhoest G, Viart L, Tillou X.

Prog Urol. 2015 Nov;25(13):766. doi: 10.1016/j.purol.2015.08.104. French. No abstract available.

PMID:
26544299
47.

Existe-t-il une différence de résultats entre la laparoscopie « hand assisted » et la laparoscopie robot-assistée pour néphrectomie donneur vivant ?

May A, Bergot C, Boutin J, Branchereau J, Karam G, Bruyere F.

Prog Urol. 2015 Nov;25(13):724. doi: 10.1016/j.purol.2015.08.018. French. No abstract available.

PMID:
26544214
48.

Prélèvement rénal pour don de rein : étude comparative de la chirurgie laparoscopique et robot-assistée.

Pradère B, Benoit T, May A, Peyronnet B, Sallusto F, Faivre d'Arcier B, Boutin J, Doumerc N, Rischmann P, Soulié M, Game X, Bruyère F.

Prog Urol. 2015 Nov;25(13):723-4. doi: 10.1016/j.purol.2015.08.017. French. No abstract available.

PMID:
26544212
49.

Quinone reductase 2 as a promising target of melatonin therapeutic actions.

Boutin JA.

Expert Opin Ther Targets. 2016;20(3):303-17. doi: 10.1517/14728222.2016.1091882. Epub 2015 Oct 14. Review.

PMID:
26465080
50.

[Impact of learning curve in renal transplantation].

Oitchayomi A, Brichart N, Monleon L, Boutin JM, Bruyère F.

Prog Urol. 2015 Dec;25(16):1146-52. doi: 10.1016/j.purol.2015.08.315. Epub 2015 Sep 26. French.

PMID:
26420676

Supplemental Content

Loading ...
Support Center